Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients

BACKGROUND: Gastrectomy with D2 dissection and adjuvant chemotherapy is the standard treatment for locally advanced gastric cancer (LAGC) in Asia. However, administering chemotherapy with sufficient intensity after gastrectomy is challenging. Several trials demonstrated the efficacy of neoadjuvant c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ota, Mitsuhiko, Saeki, Hiroshi, Uehara, Hideo, Matsuda, Yoshiko, Tsutsumi, Satoshi, Kusumoto, Tetsuya, Yasui, Hisateru, Ubukata, Yasunari, Yamaguchi, Shohei, Orita, Hiroyuki, Izawa, Naoki, Kakizoe, Saburo, Shimokawa, Mototsugu, Yoshizumi, Tomoharu, Kakeji, Yoshihiro, Mori, Masaki, Oki, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468941/
https://www.ncbi.nlm.nih.gov/pubmed/37368093
http://dx.doi.org/10.1007/s10147-023-02373-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468941/
https://www.ncbi.nlm.nih.gov/pubmed/37368093
http://dx.doi.org/10.1007/s10147-023-02373-3

Ejemplares similares